Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
RECOMBINANT FUSION POLYPEPTIDE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/037289
Kind Code:
A3
Abstract:
Disclosed are a recombinant fusion polypeptide, a preparation method therefor, and a use thereof. A recombinant fusion polypeptide, said recombinant fusion polypeptide being expressed as the following general formula: X-linker1-Y, Y-linker1-X, X-linker2-Y, Y-linker2-X, where X is PRCWRGEGGGGIVRRADRAAVPGGGGRGD and Y is Acetyl-SDKPGGGGTSLDASIIWAMMQNGGGGLSKL. The treatment usage includes pulmonary fibrosis, hepatic fibrosis, skin fibrosis, kidney fibrosis, cardiac fibrosis, and lung tissue lesion.

Inventors:
KANG ZHIAN (CN)
Application Number:
PCT/CN2020/123551
Publication Date:
April 22, 2021
Filing Date:
October 26, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANJING ANJI BIOLOGICAL TECH CO LTD (CN)
International Classes:
C07K19/00; A61K38/16; A61P1/16; A61P9/00; A61P11/00; A61P13/12; A61P17/00; A61P31/04; A61P31/10; A61P31/12; A61P33/02
Foreign References:
CN110511285A2019-11-29
CN105713095A2016-06-29
CN1328569A2001-12-26
Attorney, Agent or Firm:
RAYTO PARTNERS, P.C. (CN)
Download PDF: